KR930703024A - 영상용 테크네튬-99m표지폴리펩티드 - Google Patents

영상용 테크네튬-99m표지폴리펩티드

Info

Publication number
KR930703024A
KR930703024A KR1019930702357A KR930702357A KR930703024A KR 930703024 A KR930703024 A KR 930703024A KR 1019930702357 A KR1019930702357 A KR 1019930702357A KR 930702357 A KR930702357 A KR 930702357A KR 930703024 A KR930703024 A KR 930703024A
Authority
KR
South Korea
Prior art keywords
formyl
polypeptide
technetium
specific binding
region
Prior art date
Application number
KR1019930702357A
Other languages
English (en)
Inventor
리챠드 티. 딘
Original Assignee
리챠드 티. 딘
다이아테크, 아이엔씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리챠드 티. 딘, 다이아테크, 아이엔씨 filed Critical 리챠드 티. 딘
Publication of KR930703024A publication Critical patent/KR930703024A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008Peptides; Proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Abstract

본원은 포유류체내를 방사성 표지시켜 영상화 시키는 방법에 관한다. 본원은 특히, 그같은 영상화에 사용될 수 있는 테크네륨-99m표지의 시약을 제공한다. 본원은 또한 테크네륨-99m과 결합하며, 포유류 체내 특정부위를 표적으로 삼는 펩티드를 제공한다.

Description

영상용 테크네튬-99m표지폴리펩티드
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (14)

  1. (a)영상화될 표적부위에 특이적으로 결합하는 특이적 결합 폴리펩티드지역과 (b) 특이적 결합 폴리펩티드지역에 공유결합적으로 결합하는, 일반식 Cp(aa)Cp[식중,Cp는 보호된 시스테인이고, (aa)는 아미노산임]의 테크네튬 결합지역으로 구성된, 테크네튬 99m표지되며, 포유류체네 표적부위를 영상화시켜주는 폴리펩티드.
  2. 제1항에 있어서, 특이적 결합 폴리펩티드직역과 Cp(aa)Cp가 하나이상의 아미노산을 통해 공유결합적으로 결합하는 폴리펩티드.
  3. 제1항에 있어서, 보호된 시스테인 이 하기 일반식의 보호그룹을 갖는 폴리 펩티드.
    -CH2-NH-CO-R
    식중 R은 C1-6의 저급알킬, 페닐 또는 저급 알킬, 하이드록시, 저급알콕시, 카복시 또는 저급 알콕시 카보닐 또는 2-, 3-, 4-, 피리딜 치환된 페닐임.
  4. 제1항에 있어서, Cp(aa) Cp가 하기 일반식을 갖는 폴리펩티드.
  5. 제1항에 있어서, 특이적 결합 폴리펩티드지역이 혈괴, 종양, 감염부위, 아테톰성 동맥경화 플락, 아미로이드 플락 또는 뼈에 특이적으로 결합하는 폴리펩티드.
  6. 제1항에 있어서, 특이적 결합 폴리펩티드 지역이 하기 아미노산 배열로 구성된 폴리펩티드에서 선택되는 폴리펩티드.
    YRALVDTLK
    RALVDTLK
    RALVDTLKFVTQAEGAK
    YAKFRETLEDTRDRMY
    AKFRETLEDTRDRMY
    YAALDLNAVANKIADFEL
    AALDLNAVANKIADFEL
    YRALVDTLKFVTEQAKGA
    RALVDTLKFVTEQAKGA
    YRALVDTEFKVKQEAGAK
    RALVDTEFKVKQEAGAK
    VGVAPGVGVAPGVGVAPG
    VPGVGVPGVGVPGVGVPGVG
    포르밀. Nleu. LF. Nleu. YK
    포르밀. MIFL
    포르밀. MLFK
    포르밀. MLFL
    포르밀. MLIL
    포르밀. MFLI
    포르밀. MLIF
    포르밀. MILF
    TKPR
    VGVAPG
    formyl MLF
    NDGDFEEIPEEYLQ
    NDGFEEIPEEY (SO5Na)LQ
    GORG
    D-Phe. PRPGGGGNGFEEIPEEYL
    RRRRRRRRRGDV
    PLYKKIIKKLLES
    RGD
    RGDS
    YIGSR
    CH3CO. YIGSRC
    EKPLQNFTLSFR
  7. 테크네튬-99m에 결합된 제6항의 폴리펩티드.
  8. 환원제 존재하에서 제1항 화합물과 테크네튬-99m을 반응시켜 만든 착물.
  9. 제8항에 있어서, 환원제가 아(亞) 디티온산이온(dithiontienion)제일주석이 온 또는 제1일철이온으로 이루어진 그룹에서 선택되는 착물.
  10. 미라환원시킨 테크네튬-99m착물의 리간드 교환을 통해, 제1항의 화합물을 테트네튬-99m으로 표지시켜 만든 착물.
  11. 선결량의 제1항 화합물과 이 화합물을 테크네튬-99m으로 표지시키기에 충분한 량의 환원제를 함유한 봉인된 바이알로 구성된 제약 제제 제조용의 킷.
  12. 표적불위에 특이적 결합폴리펩티드 지역을 통해 결합하는 테크네큠-99m표지된 유효진단량의 제1항 폴리펩티드를 투여하는 단계와 집적된 테트네튬-99m을 검측해내는 단계로 구성되는, 포유류체내 표적부위 영상화방법.
  13. 펩티드를 시험관내에서 화학적으로 합서아느 제1항 펩티드의 제조방법.
  14. 제13항에 있어서, 펩티드가 고상펩티드 합성법에 의해 합성되는 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930702357A 1991-02-08 1992-02-07 영상용 테크네튬-99m표지폴리펩티드 KR930703024A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65301291A 1991-02-08 1991-02-08
US653,012 1991-02-08
PCT/US1992/000757 WO1992013572A1 (en) 1991-02-08 1992-02-07 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING

Publications (1)

Publication Number Publication Date
KR930703024A true KR930703024A (ko) 1993-11-29

Family

ID=24619134

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930702357A KR930703024A (ko) 1991-02-08 1992-02-07 영상용 테크네튬-99m표지폴리펩티드

Country Status (12)

Country Link
US (7) US5654272A (ko)
EP (1) EP0570493B1 (ko)
JP (1) JP2774378B2 (ko)
KR (1) KR930703024A (ko)
AT (1) ATE188387T1 (ko)
BR (1) BR1100906A (ko)
CA (1) CA2101942C (ko)
DE (1) DE69230525T2 (ko)
DK (1) DK0570493T3 (ko)
ES (1) ES2141102T3 (ko)
GR (1) GR3032851T3 (ko)
WO (1) WO1992013572A1 (ko)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792444A (en) * 1989-05-09 1998-08-11 The General Hospital Corporation Labeled chemotactic peptides to image focal sites of infection or inflammation
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5736122A (en) * 1991-02-08 1998-04-07 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
JP2774378B2 (ja) * 1991-02-08 1998-07-09 ダイアテク,インコーポレイテッド 映像用テクネチウム−99m標識化ポリペプチド
US6107459A (en) * 1991-02-08 2000-08-22 Diatide, Inc. Technetium-99m labeled peptides for diagnostic imaging
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5645815A (en) 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5552525A (en) * 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US6019958A (en) * 1991-02-08 2000-02-01 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5993775A (en) * 1991-11-27 1999-11-30 Diatide, Inc. Radioactively labeled peptides comprising a single thiol moiety
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5738838A (en) * 1992-02-20 1998-04-14 Rhomed Incorporated IKVAV peptide radiopharmaceutical applications
DE69231586T2 (de) * 1992-01-03 2001-07-19 Rhomed Inc Pharmazeutische anwendungen auf der basis von peptid-metall-ionen
US5989519A (en) * 1992-03-13 1999-11-23 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
DE69332879T2 (de) * 1992-03-13 2004-02-19 Diatide, Inc. Technetium-99-markierte peptide zur visualisierung vom entzuendungen
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
ATE196094T1 (de) * 1992-05-21 2000-09-15 Diatide Inc Technetium-99m markierte peptide zur bilderzeugung von thrombus
US5968476A (en) * 1992-05-21 1999-10-19 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5750088A (en) 1993-03-30 1998-05-12 The Dupont Merck Pharmaceutical Company Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
DE69431052T2 (de) * 1993-04-08 2003-03-13 Diatide Inc Radiomarkierte verbindungen zur thrombus-bilderzeugung
US5464934A (en) * 1993-05-14 1995-11-07 Mallinckrodt Medical, Inc. Metal chelates as spacer compounds in biologically active peptides
DE69426673T2 (de) * 1993-06-23 2001-09-20 Diatide Inc Radiomarkierte somatostatin derivate zur abbildung und zur therapeutischen verwendung
DE69408145T2 (de) * 1993-07-19 1998-09-03 Resolution Pharm Inc Hydrazine mit einer n3s konfiguration als radionukleide chelatoren
AU698176B2 (en) * 1993-07-28 1998-10-29 Cis Bio International Radiolabelled glucans
US5449761A (en) * 1993-09-28 1995-09-12 Cytogen Corporation Metal-binding targeted polypeptide constructs
JPH07149668A (ja) * 1993-11-30 1995-06-13 Kanegafuchi Chem Ind Co Ltd アミロイド沈着検出用物質
US5480970A (en) * 1993-12-22 1996-01-02 Resolution Pharmaceuticals Metal chelators
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
DK0772459T3 (da) * 1994-05-02 2003-06-02 Diatide Inc Technetium-99m mærkede billeddannende midler.
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5827498A (en) * 1994-06-07 1998-10-27 Nihon Medi-Physics Co., Ltd. Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide
US5662885A (en) * 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
CA2165228A1 (en) * 1994-12-27 1996-06-28 Yoshitoshi Itaya Metal chelate forming peptides and use thereof
EP0727225A3 (en) * 1995-02-14 1997-01-15 Sonus Pharma Inc Compositions and methods for directed ultrasonic imaging
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
US6068829A (en) 1995-09-11 2000-05-30 The Burnham Institute Method of identifying molecules that home to a selected organ in vivo
US6331285B1 (en) 1996-06-05 2001-12-18 Palatin Technologies, Inc. Structurally determined cyclic metallo-constructs and applications
US7341730B1 (en) * 1998-07-13 2008-03-11 University Of Southern California Inhibitors of angiogenesis and tumor growth
AU1179600A (en) * 1998-11-13 2000-06-05 Kyowa Hakko Kogyo Co. Ltd. Physiologically active peptides
US6436204B1 (en) * 1998-11-20 2002-08-20 Kennametal Pc Inc. Diamond coated cutting tools and method of manufacture
US6314314B1 (en) 1999-01-14 2001-11-06 Seth J. Karp Method for locating an internal bleeding site in a human body
US6808698B1 (en) 1999-03-26 2004-10-26 Bristol-Myers Squibb Pharma Company Method for localization of blood clots
US6254852B1 (en) 1999-07-16 2001-07-03 Dupont Pharmaceuticals Company Porous inorganic targeted ultrasound contrast agents
CA2376245A1 (en) * 1999-07-29 2001-02-08 Dyax Corp. Binding moieties for fibrin
US6685914B1 (en) 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
US7385025B2 (en) 2000-12-19 2008-06-10 Palatin Technologies, Inc. Metallopeptide compounds
US6984373B2 (en) * 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
CA2445826C (en) 2001-05-02 2014-03-25 Purdue Research Foundation Treatment and diagnosis of macrophage mediated disease
KR100417218B1 (ko) * 2001-06-13 2004-02-05 한국원자력연구소 TC-99m 트리카보닐 시스테인 또는 그 유도체를포함하는 신장기능 진단용 방사성의약품
JP4510444B2 (ja) * 2001-07-10 2010-07-21 ジーイー・ヘルスケア・アクスイェ・セルスカプ ペプチドベースの化合物
US8043602B2 (en) 2002-02-07 2011-10-25 Endocyte, Inc. Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
US8043603B2 (en) 2002-02-07 2011-10-25 Endocyte, Inc. Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
US8623822B2 (en) * 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
EP1587944A4 (en) * 2002-03-01 2007-03-21 Dyax Corp KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
ES2398393T3 (es) 2002-03-01 2013-03-15 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico y terapia
US7794693B2 (en) * 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
PT2151250E (pt) * 2002-05-06 2013-12-09 Endocyte Inc Agentes de formação de imagem direccionados para vitamina
US7122189B2 (en) 2002-08-13 2006-10-17 Enzon, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
PL2949658T3 (pl) 2003-03-03 2018-11-30 Dyax Corp. PEPTYDY SPECYFICZNIE WIĄŻĄCE SIĘ Z RECEPTOREM HGF (cMET) I ICH ZASTOSOWANIA
EP1466629A1 (en) 2003-04-11 2004-10-13 BRACCO IMAGING S.p.A. Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "CEST" applications
US7317104B2 (en) 2003-06-13 2008-01-08 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US7319149B2 (en) * 2003-06-13 2008-01-15 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
GB0317815D0 (en) * 2003-07-30 2003-09-03 Amersham Health As Imaging agents
US20060024229A1 (en) * 2004-07-29 2006-02-02 Seth Karp Method and product for locating an internal bleeding site
WO2006045503A1 (en) * 2004-10-19 2006-05-04 Lonza Ag Method for solid phase peptide synthesis
WO2006093973A2 (en) * 2005-02-28 2006-09-08 University Of Massachusetts Biomarkers of vulnerable a therosclerotic plaques and methods of use
WO2007006041A2 (en) 2005-07-05 2007-01-11 Purdue Research Foundation Imaging and therapeutic method using monocytes
US8795633B2 (en) 2005-09-23 2014-08-05 Purdue Research Foundation Multiphoton in vivo flow cytometry method and device
JP2010509570A (ja) 2006-11-03 2010-03-25 パーデュー・リサーチ・ファウンデーション エクスビボフローサイトメトリーの方法および装置
US20080167544A1 (en) * 2006-12-01 2008-07-10 Cold Spring Diagnostics, Inc. Compositions And Methods For Locating An Internal Bleeding Site
CA2671564A1 (en) * 2006-12-11 2008-06-19 Ge Healthcare As Radiolabelled peptide based compounds and uses thereof
AU2008213702B2 (en) 2007-02-07 2014-04-24 Purdue Research Foundation Positron emission tomography imaging method
US8961926B2 (en) 2007-05-25 2015-02-24 Purdue Research Foundation Method of imaging localized infections
US20090016985A1 (en) * 2007-07-11 2009-01-15 Enzon Pharmaceuticals, Inc. Polymeric drug delivery system containing a multi-substituted aromatic moiety
CA2727803C (en) 2008-05-13 2013-03-12 University Of Kansas Metal abstraction peptide (map) tag and associated methods
EP2147684A1 (en) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Diagnostic Agents Selective Against Metalloproteases
BRPI1009900A2 (pt) 2009-03-19 2016-03-15 Wyeth Llc métodos para a preparação de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]fosfônico e seus precursores
WO2010121133A2 (en) 2009-04-17 2010-10-21 The General Hospital Corporation Multimodal imaging of fibrin
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
US20150344523A1 (en) 2014-05-05 2015-12-03 California Institute Of Technology Mutant akt-specific capture agents, compositions, and methods of using and making
EP3322716A2 (en) 2015-07-15 2018-05-23 California Institute of Technology Il-17f-specific capture agents, compositions, and methods of using and making
WO2017030893A1 (en) 2015-08-14 2017-02-23 Endocyte, Inc. Method of imaging with a chelating compound
US20170319722A1 (en) 2016-04-04 2017-11-09 Indi Molecular, Inc. Cd8-specific capture agents, compositions, and methods of using and making
US11884707B2 (en) 2016-09-29 2024-01-30 Regeneron Pharmaceuticals, Inc. Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same
US11719705B2 (en) 2017-06-15 2023-08-08 Indi Molecular, Inc. IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making
US11638764B2 (en) 2018-11-08 2023-05-02 Indi Molecular, Inc. Theranostic capture agents, compositions, and methods of using and making
US20200291391A1 (en) 2019-03-12 2020-09-17 Indi Molecular, Inc. Cross-linked epitopes and methods of use thereof
US20200371101A1 (en) 2019-05-20 2020-11-26 Indi Molecular, Inc. Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (ido1)
US11414460B2 (en) 2019-07-19 2022-08-16 Institute For Systems Biology KRAS-specific capture agents, compositions, and methods of making and using
WO2022098745A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, delivery systems, and methods useful in tumor therapy
WO2022098743A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
US4427646A (en) * 1981-04-02 1984-01-24 Research Corporation Use of radiolabeled peptide derived from crosslinked fibrin to locate thrombi in vivo
CA1183008A (en) * 1981-04-10 1985-02-26 Terence H. Colford Flexible couplings
US4444690A (en) * 1982-02-25 1984-04-24 University Patents, Inc. Technetium chelates
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
US4575556A (en) * 1982-11-08 1986-03-11 Medi-Physics, Inc. Bifunctional chelating agents
US4434151A (en) * 1982-11-08 1984-02-28 Medi-Physics, Inc. Bifunctional chelating agents
US4571430A (en) * 1982-11-08 1986-02-18 Medi-Physics, Inc. Homocysteine and homocysteinamide derivatives
US4673562A (en) * 1983-08-19 1987-06-16 The Children's Medical Center Corporation Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
US4638051A (en) * 1984-04-30 1987-01-20 The Johns Hopkins University Brain imaging radiopharmaceuticals
ATE66469T1 (de) * 1985-01-14 1991-09-15 Neorx Corp Metall-radionuklid markiertes protein fuer diagnose und therapie.
US4844895A (en) * 1985-11-01 1989-07-04 New York University Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
FR2604371B1 (fr) * 1986-09-30 1990-07-06 Toulouse Inst Nal Sciences App Procede et dispositif d'echange entre un gaz et un liquide
US4729525A (en) * 1986-12-12 1988-03-08 Trw Vehicle Safety Systems Inc. Seat belt retractor with electrically actuatable locking mechanism
US4965392A (en) * 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
DE3889956T2 (de) * 1987-03-26 1994-12-22 Neorx Corp Metall-Radionuklid-markierte Proteine und Glykoproteine zur Diagnose und Therapie.
WO1989000051A1 (en) * 1987-07-07 1989-01-12 Cytrx Biopool Ltd. Fibrin-binding compound and method
US4843647A (en) * 1987-08-31 1989-07-04 Burlington Industries, Inc. Cold weather system
US4889524A (en) * 1987-09-04 1989-12-26 Haemonetics Corporation Portable centrifuge apparatus
DE3731266A1 (de) * 1987-09-17 1989-04-06 Kernforschungsz Karlsruhe Huellmaterial fuer supraleitende draehte
US5217705A (en) * 1987-09-25 1993-06-08 Neorx Corporation Method of diagnosing blood clots using fibrin-binding proteins
WO1989002752A1 (en) * 1987-09-25 1989-04-06 Genentech, Inc. Method of diagnosing blood clots using fibrin-binding proteins
GB8723547D0 (en) * 1987-10-07 1987-11-11 Automotive Prod Plc Clutch control
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
JP2547263B2 (ja) * 1987-12-10 1996-10-23 ラ・ジョラ・キャンサー・リサーチ・ファウンデーション 立体配座的に安定化された細胞付着ペプチド
WO1989010759A1 (en) * 1988-04-29 1989-11-16 Mallinckrodt, Inc. Diaminedithiol chelating agents for radiopharmaceuticals
WO1989010135A1 (en) * 1988-04-29 1989-11-02 New England Deaconess Hospital Corporation Hybrid peptides and methods of their use
US4896388A (en) * 1988-05-10 1990-01-30 Bard Maurice R Water pillow
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
WO1989012680A1 (en) * 1988-06-20 1989-12-28 Washington University USE OF MODIFIED tPA TO DETECT BLOOD CLOTS
FR2634400B1 (fr) * 1988-07-19 1991-12-06 Becker Arnaud Broyeur a marteaux pour le dechiquetage d'objets metalliques muni d'un dispositif de protection du tambour d'entrainement des marteaux
EP0427759B1 (en) * 1988-08-03 1998-10-28 The Regents Of The University Of California Probe for high resolution nmr with sample reorientation
US5180816A (en) * 1988-08-24 1993-01-19 Centocor One vial method for labeling protein/linker conjugates with technetium-99M
US5372933A (en) * 1988-10-03 1994-12-13 The Scripps Research Institute Polypeptides that mimic receptor-induced binding sites, and methods of using same
EP0392006B1 (en) * 1988-10-14 1993-12-01 BASF Corporation Method of making a free-flowing spray-dried edible powder comprising an oil
FR2639232A1 (fr) * 1988-10-21 1990-05-25 Sanofi Sa Medicaments contenant une interleukine-2 glycosylee
WO1990006323A2 (en) * 1988-11-29 1990-06-14 Centocor, Inc. Chimeric proteins incorporating a metal binding protein
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
US5196510A (en) * 1988-12-29 1993-03-23 Cytogen Corporation Molecular recognition units
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
US5095111A (en) * 1989-03-17 1992-03-10 The John Hopkins University Thiolactone bifunctional chelating agents for diagnostic and therapeutic products
JPH02268197A (ja) * 1989-04-07 1990-11-01 Ichikawa Gosei Kagaku Kk 新規ペプチド及びその製造用中間体
CA2016235C (en) * 1989-05-09 2002-03-12 Alan J. Fischman Labeled chemotactic peptides to image focal sites of infection or inflammation
GB8914020D0 (en) * 1989-06-19 1989-08-09 Antisoma Ltd Synthetic peptides for use in thrombus detection
US5395609A (en) * 1989-06-19 1995-03-07 Antisoma Limited Synthetic peptides for use in tumor detection
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
EP0410539A1 (en) * 1989-07-28 1991-01-30 Merck & Co. Inc. Fibrinogen receptor antagonists
EP0410537A1 (en) * 1989-07-28 1991-01-30 Merck & Co. Inc. Fibrinogen receptor antagonists
CA2021950A1 (en) * 1989-07-28 1991-01-29 Ruth F. Nutt Fibrinogen receptor antagonists
US5023233A (en) * 1989-07-28 1991-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
EP0410540A1 (en) * 1989-07-28 1991-01-30 Merck & Co. Inc. Fibrinogen receptor antagonists
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
ATE172879T1 (de) * 1989-08-09 1998-11-15 Rhomed Inc Direkte radioetikettierung von antikörpern und sonstigen proteinen mittels technetium oder rhenium
US5328840A (en) * 1989-08-15 1994-07-12 The Research Foundation Of The State University Of New York Method for preparing targeted carrier erythrocytes
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
FR2651077B1 (fr) * 1989-08-18 1994-06-10 Letourneur Gregoire Dispositif de traitement d'echo notamment acoustique dans une ligne telephonique
NZ235564A (en) * 1989-10-13 1993-10-26 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical compositions
NZ235563A (en) * 1989-10-13 1993-04-28 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical composition
AU6470590A (en) * 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US5067529A (en) * 1989-10-30 1991-11-26 Depressurized Technologies International, Inc. Aerosol can recycling apparatus and methods
US5086069A (en) * 1990-02-05 1992-02-04 Rorer Pharmaceutical Corporation Anti-thrombotic peptide and pseudopeptide derivatives
US5190920A (en) * 1990-09-24 1993-03-02 W. R. Grace & Co.-Conn. Method for using synthetic analogs of thrombospondin for inhibiting metastasis activity
IL97459A0 (en) * 1990-03-09 1992-06-21 Hybritech Inc Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
WO1991015515A1 (en) * 1990-04-06 1991-10-17 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
WO1992005154A1 (en) * 1990-09-14 1992-04-02 Mallinckrodt Medical, Inc. Novel nitrogen-sulfur ligands useful in radiographic imaging agents
US5382654A (en) * 1992-02-05 1995-01-17 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical preparations containing them
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
JP2774378B2 (ja) * 1991-02-08 1998-07-09 ダイアテク,インコーポレイテッド 映像用テクネチウム−99m標識化ポリペプチド
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5736122A (en) * 1991-02-08 1998-04-07 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US5552525A (en) * 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
EP0574545B1 (en) * 1991-03-06 1994-11-30 G.D. Searle & Co. Phenyl amidines derivatives useful as platelet aggregation inhibitors
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5220050A (en) * 1991-05-17 1993-06-15 G. D. Searle & Co. Peptide mimetic compounds useful as platelet aggregation inhibitors
JP3497164B2 (ja) * 1991-06-28 2004-02-16 スミスクライン・ビーチャム・コーポレイション 二環式フィブリノーゲン拮抗薬
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
US5250679A (en) * 1991-10-18 1993-10-05 Genentech, Inc. Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5371184A (en) * 1992-02-05 1994-12-06 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
ATE196094T1 (de) * 1992-05-21 2000-09-15 Diatide Inc Technetium-99m markierte peptide zur bilderzeugung von thrombus
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5380646A (en) * 1992-10-19 1995-01-10 Temple University Of The Commonwealth System Of Higher Education Thrombus detection using radiolabelled disintegrins
EP0602900B1 (en) * 1992-12-14 1997-03-12 Nalco Chemical Company Trihydrate crystal modification in the bayer process
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
DE69431052T2 (de) * 1993-04-08 2003-03-13 Diatide Inc Radiomarkierte verbindungen zur thrombus-bilderzeugung
US5449761A (en) * 1993-09-28 1995-09-12 Cytogen Corporation Metal-binding targeted polypeptide constructs
EP0750610B1 (en) * 1994-03-18 2001-12-12 Diatide, Inc. Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis
DK0772459T3 (da) * 1994-05-02 2003-06-02 Diatide Inc Technetium-99m mærkede billeddannende midler.

Also Published As

Publication number Publication date
JP2774378B2 (ja) 1998-07-09
ATE188387T1 (de) 2000-01-15
AU658617B2 (en) 1995-04-27
WO1992013572A1 (en) 1992-08-20
DE69230525T2 (de) 2000-06-21
AU1411792A (en) 1992-09-07
US5681541A (en) 1997-10-28
DE69230525D1 (de) 2000-02-10
DK0570493T3 (da) 2000-06-26
US5811394A (en) 1998-09-22
CA2101942C (en) 2001-01-30
US5788960A (en) 1998-08-04
ES2141102T3 (es) 2000-03-16
EP0570493A1 (en) 1993-11-24
BR1100906A (pt) 2002-04-02
CA2101942A1 (en) 1992-08-09
JPH06503352A (ja) 1994-04-14
US5888474A (en) 1999-03-30
EP0570493B1 (en) 2000-01-05
GR3032851T3 (en) 2000-07-31
US5849260A (en) 1998-12-15
US5654272A (en) 1997-08-05
US5879658A (en) 1999-03-09

Similar Documents

Publication Publication Date Title
KR930703024A (ko) 영상용 테크네튬-99m표지폴리펩티드
EP0630265B1 (en) TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION
KR960700758A (ko) 진단 이미지화를 위한 테크네튬-99m 라벨링된 펩티드(TECHNETIUM-99m LABELED PEPTIDES FOR DIAGNOSTIC IMAGING)
US5326778A (en) Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
FI102540B (fi) Kelatoivan ryhmän sisältäviä somatostatiinipeptidijohdannaisia diagnos tista käyttöä varten
AU638127B2 (en) A bifunctional dtpa-type ligand
AU674853B2 (en) Carboxamide modified polyamine chelators and radioactive complexes and conjugates
US5808003A (en) Polyaminocarboxylate chelators
EP0452858B1 (en) Metal complexes of acid adducts to dioxime ligands useful in labelling proteins and other amine-containing compounds
US5395609A (en) Synthetic peptides for use in tumor detection
KR940701275A (ko) 영상화용 테크네튬-99m 표지화 펩티드
JPH10502931A (ja) ペプチド誘導の放射性核種キレート化剤
JPH0791317B2 (ja) キヤリヤ−分子の金属イオン標識化
Greenland et al. Solid-Phase Synthesis of Peptide Radiopharmaceuticals Using Fmoc-N-ε-(Hynic-Boc)− Lysine, a Technetium-Binding Amino Acid: Application to Tc-99m-Labeled Salmon Calcitonin
KR940018398A (ko) 혈관 질병 진단제
EP0693941A1 (en) Radiolabeled compounds for thrombus imaging
Gniazdowska et al. Synthesis, radiochemistry and stability of the conjugates of technetium-99m complexes with Substance P
Martinage et al. Synthesis and biological evaluation of a new triazole–oxotechnetium complex
US20020094316A1 (en) Polypodal chelants for metallopharmaceuticals
US5989519A (en) Technetium-99m labeled peptides for imaging inflammation
WO2023222558A1 (en) Precursor and theranostic radiotracer with improved tumor retention
KR100567001B1 (ko) 시스테인 유도체 및 이를 이용한 금속 트리카보닐 착화물,이들의 제조 방법 및 이들을 포함하는 조영제
AU658617C (en) Technetium-99m labeled polypeptides for imaging
Herrick Group 6 and 7 Organometallic Bioconjugates Prepared from Amino Acids, Peptides or Proteins
JPH11505852A (ja) 隔離された画像診断剤

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL